| Literature DB >> 31978424 |
Pengwei Luan1, Jiazhen Xu2, Xinyue Ding2, Qianfei Cui1, Lixian Jiang2, Yulan Xu1, Yuying Zhu2, Ruixiang Li2, Guoqiang Lin2, Ping Tian3, Jiange Zhang4.
Abstract
Salvianolate has been widely used for the treatment of cerebrovascular diseases. However, the detailed molecular mechanism of how it alleviates cerebral ischaemia-reperfusion injury is not well understood. In the present study, we investigated the neuroprotective effects of salvianolate in acute cerebral infarction using the PC12 cell oxygen-glucose deprivation (OGD) model in vitro and the rat transient middle cerebral artery occlusion (MCAO) model in vivo. The results showed that the salvianolate significantly reduced the level of reactive oxygen species and inhibited the Caspase-3 signalling pathway in vitro; at the same time, in vivo experiments showed that salvianolate obviously reduced the infarct area (12.9%) and repaired cognitive function compared with the model group (28.28%). In conclusion, our data demonstrated that the salvianolate effectively alleviated cerebral ischaemia-reperfusion injury via suppressing the Caspase-3 signalling pathway.Entities:
Keywords: Caspase-3 signal pathway; Ischaemia-reperfusion injury; Reactive oxygen species; Salvianolate
Year: 2020 PMID: 31978424 DOI: 10.1016/j.ejphar.2020.172944
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432